Dated disclosed rounds · latest 2021-04-01
Later stage / growth
Exscientia
AI drug discovery
VerifiedSeries DOxford
- Companies House
- 13483814
- GLEIF LEI
- 213800XOQHH5CV85AD30
- Latest evidence
- 2021-04-01
- Evidence snapshot
- 2026-08-25
Exact award notices · latest No exact award match
2026-08-25T03:54:31.471Z
Jun 2026
Signals organise dated evidence; they do not score growth, revenue, creditworthiness or investment performance.
Evidence timeline
5 dated observations
Funding, procurement, registry and identifier records are placed on one chronology. Each row says whether it is a source fact, a record observation or reference metadata; no inferred event is inserted.
RegistryRecord observation Status observed: Active
Snapshot evidence only; this row does not claim the status changed on this date.
IdentifierReference metadata LEI record updated
213800XOQHH5CV85AD30 · registration LAPSED
IdentifierReference metadata LEI first registered
213800XOQHH5CV85AD30
RegistryRegistry fact Company incorporated
EXSCIENTIA LIMITED · company 13483814
FundingSource fact Series D
$225M equity (plus up to $300M SoftBank commitment; up to $525M total) · 10 named investors
Latest disclosed round
Series D
- Date
- 2021-04-01
- Amount
- USD 225m
- Sector
- Biotech & techbio
- Companies House
- 13483814
- ONS region
- South East
Evidence status
Directory ready
- Identity
- Verified
- Match
- High — exact company number and aligned registered name
- Operating status
- active
- Data origins
- Core directory, Growth Network, Live Chris T D1
Capital network
11 linked investors
Lead, participant, lender and other retained roles remain distinct where the source supports them. Every relationship below names its source layer, observation date, match method and publication state.
SoftBank Vision Fund 2leadAir Street CapitalparticipantBlackRockparticipantBristol Myers SquibbparticipantCasdin CapitalparticipantFarallon CapitalparticipantGT Healthcare CapitalparticipantMarshall WaceparticipantMubadala Investment CompanyparticipantNovo HoldingsparticipantPivotal bioVenture Partnersparticipant
| Investor | Role | Date | Source | Match / state |
|---|---|---|---|---|
| SoftBank Vision Fund 2 | lead | 2021-04-01 | UKTN ↗ · Exscientia ↗ | reviewed canonical company and investor alias resolutionsource-linked · published |
| Air Street Capital | participant | 2026-08-25 | Airstreet ↗ | reviewed canonical company and investor alias resolutionsource-linked · published |
| BlackRock | participant | 2021-04-01 | UKTN ↗ · Exscientia ↗ | reviewed canonical company and investor alias resolutionsource-linked · published |
| Bristol Myers Squibb | participant | 2021-04-01 | UKTN ↗ · Exscientia ↗ | reviewed canonical company and investor alias resolutionsource-linked · published |
| Casdin Capital | participant | 2021-04-01 | UKTN ↗ · Exscientia ↗ | reviewed canonical company and investor alias resolutionsource-linked · published |
| Farallon Capital | participant | 2021-04-01 | UKTN ↗ · Exscientia ↗ | reviewed canonical company and investor alias resolutionsource-linked · published |
| GT Healthcare Capital | participant | 2021-04-01 | UKTN ↗ · Exscientia ↗ | reviewed canonical company and investor alias resolutionsource-linked · published |
| Marshall Wace | participant | 2021-04-01 | UKTN ↗ · Exscientia ↗ | reviewed canonical company and investor alias resolutionsource-linked · published |
| Mubadala Investment Company | participant | 2021-04-01 | UKTN ↗ · Exscientia ↗ | reviewed canonical company and investor alias resolutionsource-linked · published |
| Novo Holdings | participant | 2021-04-01 | UKTN ↗ · Exscientia ↗ | reviewed canonical company and investor alias resolutionsource-linked · published |
| Pivotal bioVenture Partners | participant | 2021-04-01 | UKTN ↗ · Exscientia ↗ | reviewed canonical company and investor alias resolutionsource-linked · published |
Funding record
1 disclosed round
Open a dated round to move directly between the company, named investors and source publication.
| Date | Stage | Amount | Investors | Named sources |
|---|---|---|---|---|
| 2021-04-01 | Series D | $225M equity (plus up to $300M SoftBank commitment; up to $525M total) | SoftBank Vision Fund 2 · Novo Holdings · BlackRock · Mubadala Investment Company · Farallon Capital · Casdin Capital · + 4 more linked | UKTN ↗ · Exscientia ↗ |
Companies House status and filing snapshot
EXSCIENTIA LIMITED
Exact company-number match from the public register. The retained status is active. Filing dates and SIC codes are registry context, not a credit or investment-quality assessment.
Registered record
- Status
- Active
- Company type
- Private Limited Company
- Country of origin
- United Kingdom
- Incorporated
- 2021-06-29
- Dissolved
- Not applicable
- Company number
- 13483814
Filing context
- Accounts category
- FULL
- Accounts made up to
- 2024-12-31
- Next accounts due
- 2026-09-30
- Confirmation made up to
- 2025-11-17
- Registry snapshot
- 2026-08-01
- Live check
- 2026-08-25T03:54:31.471Z
Former registered names: EXSCIENTIA HOLDINGS LIMITED
64209Activities of other holding companies n.e.c.72190Other research and experimental development on natural sciences and engineering
Global legal-entity identifier
213800XOQHH5CV85AD30
Exact company-number match to the GLEIF golden-copy data. An LEI is an identifier for a legal entity; it is not a credit, risk or investment-quality rating.
GLEIF record
- Legal name
- EXSCIENTIA PLC
- Entity status
- ACTIVE
- Jurisdiction
- GB
- Registration status
- LAPSED
- Last updated
- 2024-08-06T00:05:44.180Z
- Next renewal
- 2024-08-05T00:00:00Z
CompanyBeacon statutory projection
EXSCIENTIA LIMITED
UK Capital Intelligence owns the capital view on this page. CompanyBeacon owns the exact legal-entity, filing, control and public-record timeline for company number 13483814.
Latest retained status
active
- Checked
- 2026-08-25T03:54:31.471Z
- Recorded change
- No change timestamp retained
- Previous status
- active
- Fund associations
- 2 dated CompanyBeacon memberships
Boundary
Verify the legal record
Fund association does not prove a current holding. Status change is a review signal, not investment performance or wrongdoing. Ownership and control are not copied into this public UKCI package.
Open CompanyBeacon record ↗Traceability
Source trail
Funding and investor claims retain named public-source links. This is a dated research snapshot, not a live cap table.